Fingerprint
Dive into the research topics where James F Nelson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Astaxanthin, meclizine, mitoglitazone, pioglitazone, alpha-ketoglutarate, mifepristone, methotrexate, and atorvastatin-telmisartan do not increase lifespan in UM-HET3 mice
Korstanje, R., Strong, R., Salmon, A. B., Bogue, M. A., Curran, S. P., Diaz, V., Fernandez, E., Ginsburg, B., Han, M., Harrison, D. E., Kaczorowski, C., Kaeberlein, M., Kennedy, B. K., Kumar, N., LaCroix-Fralish, M., Leiser, S. F., Nelson, J. F., Polymenis, M., Reifsnyder, P. C. & Rosenthal, N. A. & 3 others, , 2026, (Accepted/In press) In: GeroScience.Research output: Contribution to journal › Article › peer-review
Open Access -
End-of-life pathology in UM-HET3 mice treated with 16 α‑hydroxyestradiol or late‑start canagliflozin
Snyder, J. M., Harrison, D. E., Korstanje, R., Ginsburg, B., Reifsnyder, P. C., Nelson, J., Leiser, S., Kaczorowski, C., Imai, D. M., Salmon, A. B., Strong, R., Ladiges, W. & Miller, R. A., Apr 2026, In: GeroScience. 48, 2, p. 1787-1797 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Correction to: Lifespan effects in male UM-HET3 mice treated with sodium thiosulfate, 16-hydroxyestriol, and late-start canagliflozin (GeroScience, (2024), 46, 5, (4657-4670), 10.1007/s11357-024-01176-2)
Miller, R. A., Harrison, D. E., Cortopassi, G. A., Dehghan, I., Fernandez, E., Garratt, M., Geisler, J. G., Ginsburg, B. C., Han, M. L., Jiang, N., Kaczorowski, C. C., Kumar, N., Leiser, S. F., Lopez‑Cruzan, M., Milne, G., Mitchell, J. R., Nelson, J. F., Reifsnyder, P. C., Salmon, A. B. & Xu, Z. & 3 others, , Aug 2025, In: GeroScience. 47, 4, p. 6093-6094 2 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access2 Link opens in a new tab Scopus citations -
Correction to: Lifespan effects in male UM-HET3 mice treated with sodium thiosulfate, 16-hydroxyestriol, and late-start canagliflozin (GeroScience, (2024), 46, 5, (4657-4670), 10.1007/s11357-024-01176-2)
Miller, R. A., Harrison, D. E., Cortopassi, G. A., Dehghan, I., Fernandez, E., Garratt, M., Geisler, J. G., Ginsburg, B. C., Han, M. L., Kaczorowski, C. C., Kumar, N., Leiser, S. F., Lopez‑Cruzan, M., Milne, G., Mitchell, J. R., Nelson, J. F., Reifsnyder, P. C., Salmon, A. B., Korstanje, R. & Rosenthal, N. & 1 others, , Oct 2025, In: GeroScience. 47, 5, p. 6663-6664 2 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Deciphering the timing and impact of life-extending interventions: temporal efficacy profiler distinguishes early, midlife, and senescence phase efficacies
Jiang, N., Cheng, C. J., Liu, Q., Strong, R., Gelfond, J. & Nelson, J. F., Dec 2025, In: Nature communications. 16, 1, 10164.Research output: Contribution to journal › Article › peer-review
Open Access